Dynavax Technologies (FRA:DYF1) Other Long Term Assets : €67.6 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Dynavax Technologies Other Long Term Assets?

Dynavax Technologies's other long-term assets for the quarter that ended in Mar. 2024 was €67.6 Mil.

Dynavax Technologies's quarterly other long-term assets declined from Sep. 2023 (€69.5 Mil) to Dec. 2023 (€68.2 Mil) but then stayed the same from Dec. 2023 (€68.2 Mil) to Mar. 2024 (€67.6 Mil).

Dynavax Technologies's annual other long-term assets increased from Dec. 2021 (€3.2 Mil) to Dec. 2022 (€3.3 Mil) and increased from Dec. 2022 (€3.3 Mil) to Dec. 2023 (€68.2 Mil).

Dynavax Technologies Other Long Term Assets Historical Data

The historical data trend for Dynavax Technologies's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dynavax Technologies Other Long Term Assets Chart

Dynavax Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

3.20

3.13

3.20

3.32

68.16

Dynavax Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															69.26	68.42	69.48	68.16	67.58

Dynavax Technologies Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Dynavax Technologies (FRA:DYF1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dynavax Technologies Corp (FRA:DYF1) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

DVAX:USA DYF1:Germany

Address

2100 Powell Street, Suite 900, Emeryville, CA, USA, 94608

Website

https://www.dynavax.com

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Dynavax Technologies (FRA:DYF1) Headlines

No Headlines